-
Mashup Score: 24Nuclear Medicine Is Big Pharma’s New Target in Cancer Race - 17 day(s) ago
As pharma giants spend billions on acquisitions of startups developing new ways to harness radiation in the fight against cancer, the chief executive officer of Perspective Therapeutics Inc. found himself getting top billing at two different industry gatherings this week.
Source: www.bloomberg.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1Union.ai • Infrastructure for AI, ML, and Data Workloads - 2 month(s) ago
Union: Infrastructure for AI, ML, and Data Workloads with Data Lineage, Caching, Observability, GPU Management, and Reproducibility.
Source: www.union.aiCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 3
The study found military personnel stationed at U.S. Marine Corps Base Camp Lejeune from 1975 to 1985 had at least a 20% higher risk for a number of cancers. The list includes some types of leukemia and lymphoma and cancers of the lung, breast, throat, esophagus and thyroid.
Source: www.wunc.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 6Functional Outcomes After Localized Prostate Cancer Treatment - 3 month(s) ago
This observational study uses registry data to compare rates of adverse functional outcomes between specific treatments for localized prostate cancer (radical prostatectomy, external beam radiotherapy, brachytherapy, or active surveillance for favorable-prognosis disease and radical prostatectomy or…
Source: jamanetwork.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 6Functional Outcomes After Localized Prostate Cancer Treatment - 3 month(s) ago
This observational study uses registry data to compare rates of adverse functional outcomes between specific treatments for localized prostate cancer (radical prostatectomy, external beam radiotherapy, brachytherapy, or active surveillance for favorable-prognosis disease and radical prostatectomy or…
Source: jamanetwork.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0Telemedicine for Cancer Care in the Time of COVID-19 - 3 month(s) ago
This Viewpoint discusses the loosening of Medicare & Medicaid restrictions regarding telemedicine during the coronavirus disease 2019 (COVID-19) pandemic.
Source: jamanetwork.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 3Opinion | The Doctor Is In, but the Patient Is Out of State - 3 month(s) ago
New Jersey puts patients at risk by restricting their telehealth options. I’m suing to change that.
Source: www.wsj.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1Startups Are Using AI to Predict Responses to Cancer Drugs - 4 month(s) ago
More accurate prognoses and treatments tailored to patients—entrepreneurs claim AI can be harnessed for breakthroughs in beating cancer. One founder is using lab-grown human organs in combination with AI to test drug efficacy.
Source: www.wsj.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2Bristol-Myers Squibb to Buy RayzeBio for $4.1 Billion - 4 month(s) ago
The deal demonstrates renewed interest in radiopharmaceutical drugs to treat cancer
Source: www.wsj.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 6ArteraAI and GenesisCare Partner to Provide Precision Cancer Therapy to Patients with Localized Prostate Cancer In Australia - 5 month(s) ago
SAN FRANCISCO & SYDNEY, December 07, 2023–ArteraAI, the developer of multimodal artificial intelligence (MMAI)-based predictive and prognostic cancer tests, and GenesisCare, one of the leading integrated cancer care providers in Australia, today announced a partnership to help bring AI-based decision making tools to Australia as part of a new clinical trial.
Source: finance.yahoo.comCategories: General Medicine News, Hem/OncsTweet
Three leading drugmakers have spent about $8 billion in the past six months to purchase companies developing radiopharmaceuticals to fight cancer https://t.co/SbEhOFEwKj